Loading clinical trials...
Loading clinical trials...
A Sofosbuvir-based Quadruple Regimen is Highly Effective in HCV Type 4-infected Egyptian Patients With DAA Treatment Failure
Conditions
Interventions
SOF/SMV/DCV/RBV
Locations
1
Egypt
Health Administration at Beni-Seuf
Bani Sweif, Egypt
Start Date
March 1, 2017
Primary Completion Date
October 31, 2017
Completion Date
October 31, 2017
Last Updated
May 14, 2020
NCT04391985
NCT04385407
NCT01708889
NCT00570336
NCT00770198
Lead Sponsor
Beni-Suef University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions